ROCKVILLE, Md., May 28, 2015 /PRNewswire/ -- TissueGene, Inc. today announced that Robert Newman, TissueGene's Chief Operating Officer, will present a company overview at the Jefferies 2015 Healthcare Conference on Thursday, June 4, at 8:00 a.m. EDT.  An audio webcast of this discussion will be accessible through the News and Events section of the Company's website. A replay of the webcast will also be accessible for a period of time following the event.   The Jefferies 2015 Global Healthcare Conference will be in held in New York from June 1 to June 4, 2015.

TissueGene, Inc.

TissueGene Inc. is a biopharmaceutical company based in Rockville, Maryland, specializing in regenerative therapies for the treatment of various orthopedic diseases. Founded in 1999, TissueGene is focused on treatment through the regeneration of damaged cartilage, joints and nerves. TissueGene has completed Phase 2 trials and has reached an agreement with the U.S. Food and Drug Administration regarding a Special Protocol Assessment (SPA) on the design, endpoints and statistical analysis plan for a Phase 3 clinical trial for Invossa™, an allogeneic cell therapy for osteoarthritis of the knee.  Information can be found at the NIH registry, www.clinicaltrials.gov. For additional information about TissueGene, Inc., please visit the Company's website at www.TissueGene.com.

Logo - https://photos.prnewswire.com/prnh/20141107/157412LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tissuegene-announces-presentation-and-webcast-at-the-jefferies-2015-healthcare-conference-300090151.html

SOURCE TissueGene, Inc.